Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Satellos Bioscience | 2025 | Post-IPO Equity | Undisclosed | Toronto |
| Willow | 2022 | Series D | Undisclosed | Mountain View |
| Forge Biologics | 2022 | Series C | Undisclosed | Grove City |
| Amylyx Pharmaceuticals | 2025 | Post-IPO Equity | Undisclosed | Cambridge |
| IDEAYA Biosciences | 2026 | Post-IPO Equity | Undisclosed | South San Francisco |
| Nuvation Bio | 2026 | Post-IPO Debt | Undisclosed | New York |
| Absci | 2026 | Post-IPO Equity | Undisclosed | Vancouver |
| Neuron23 | 2026 | Grant | Undisclosed | San Francisco |
| Orchestra BioMed | 2026 | Post-IPO Debt | Undisclosed | New Hope |
| Relay Therapeutics | 2026 | Post-IPO Equity | Undisclosed | Cambridge |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 1 | Satellos Bioscience | Post-IPO Equity | Undisclosed | Toronto, Canada |
| 2 | Willow | Series D | Undisclosed | Mountain View, United States |
| 3 | Forge Biologics | Series C | Undisclosed | Grove City, United States |
| 4 | Amylyx Pharmaceuticals | Post-IPO Equity | Undisclosed | Cambridge, United States |
| 5 | IDEAYA Biosciences | Post-IPO Equity | Undisclosed | South San Francisco, United States |
| 6 | Nuvation Bio | Post-IPO Debt | Undisclosed | New York, United States |
| 7 | Absci | Post-IPO Equity | Undisclosed | Vancouver, United States |
| 8 | Neuron23 | Grant | Undisclosed | San Francisco, United States |
| 9 | Orchestra BioMed | Post-IPO Debt | Undisclosed | New Hope, United States |
| 10 | Relay Therapeutics | Post-IPO Equity | Undisclosed | Cambridge, United States |
Satellos Bioscience is a private regenerative medicine company developing novel therapeutics that stimulate or restore muscle regeneration.
Willow is a women's healthcare company that develops pumping bras and breast pumps for women.
Forge Biologics is a gene therapy development engine, enabling access to life changing gene therapy programs.
Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.
IDEAYA Biosciences is an oncology-focused biotechnology company that develops therapeutics for patients with genetically-defined cancers.
Nuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology.
Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential of proteins
Neuron23 is a developer of drugs intended to treat Parkinson's disease and Alzheimer's disease.
Orchestra BioMed is a biomedical innovation company that provides high-impact solutions for large unmet needs in procedure-based medicine.
Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.
Opus Genetics a clinical-stage biopharmaceutical company, develops and commercializes therapies for patients with ophthalmic disorders.
Allogene Therapeutics is a biotechnology company catalyzing cancer treatment through the development of CAR T therapy.
Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.
Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.
Hyperfine makes MRI accessible to every patient regardless of income or resources.
Imperative Care is singularly dedicated to finding meaningful answers to unsolved problems in stroke.
Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.
Kardigan develops personalized medicines using AI and data to target and treat the root causes of cardiovascular diseases.
Twin Health is a metabolic health platform that offers sensors, AI to reverse, prevent and improve chronic metabolic diseases.
Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.
Zucara Therapeutics is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in patients with diabetes.
Orpyx Medical Technologies develops sensor-based technologies and self-monitoring devices in medical and athletic spaces.
Genome Medical is a telegenomics technology and services company allowing access to genomic-based medicine.
Bridge to Life is a supplier of preservation solutions globally with a focus on innovation in organ preservation and machine perfusion.
Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers.
Perceptive Advisors has invested in 134 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Perceptive Advisors's top investment sectors include Health Care, Biotechnology, Medical, Pharmaceutical, Biopharma. The firm invests across 26 different industry categories.
Among tracked funding rounds, Kardigan received $254.0M in a Series B round. Perceptive Advisors's total known invested capital is $9.5B.
Perceptive Advisors's average investment size is $101.5M across its portfolio of 134 companies.
Recent Perceptive Advisors portfolio additions include Satellos Bioscience, Willow, Forge Biologics, Amylyx Pharmaceuticals, IDEAYA Biosciences. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors